PATENT CLAIM ANALYSIS

Application Number: 16248110
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-07
Patent Classification: ["514", "649000"]

Abstract:
The invention provides compounds formula (I) and salts thereof: wherein R 1 -R 4  have any of the values defined in the specification. The compounds are useful for treating conditions including Alzheimer's disease, Parkinson's disease, diabetes, cancer, inflammation, hyperresponsiveness, allergic conditions, asthma, and psychotic disorders such as schizophrenia. The compounds are also useful to lower IL-4, IL-5, or IL-15 levels in an animal.

Claim (Index 3):
The compound of  claim 2 , wherein R 1  is isopropyl or cyclopropylmethyl.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 99.0
- Lexical Diversity: 1.39655
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15550259', '15878297', '14344867', '15121324', '15873704']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7411627986888368
- 35 USC 102 Novelty (BERT): 0.5392283639511608
- Combined Prediction Score: 0.7209693552150692
- Mean Citation Score: 310.575246
- Max Citation Score: 344.34482
- Similarity Product: 195.2514052044225

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test